Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
yiqi zhixue
- Development stage
- Unknown
- Lead developer
- 中国中医科学院望京医院
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Yiqi Zhixue is a Traditional Chinese Medicine (TCM) formula developed by Wangjing Hospital, primarily administered as granules. The formula is designed according to TCM principles to 'supplement Qi' and 'promote hemostasis,' specifically targeting gastrointestinal bleeding in patients with acute coronary syndrome (ACS) who have undergone percutaneous coronary intervention (PCI). These patients are typically treated with intensive antithrombotic regimens, such as dual antiplatelet therapy, which significantly increases the risk of gastrointestinal mucosal damage and hemorrhage. Yiqi Zhixue aims to mitigate these risks through a multi-component, multi-target approach characteristic of herbal medicine, potentially offering a protective effect on the gastric mucosa and improving clinical outcomes in the post-PCI setting.
- Brand names
- Yiqi Zhixue granules益气止血颗粒
- Other names
- Yiqi Zhixue granulesSupplementing Qi and Hemostasis Formula
Beyond the preview
Go deeper on yiqi zhixue.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on yiqi zhixue.